No difference in IGF-1 receptor or GH receptor gene expression across worsening stages of NAFLD/NASH compared to that in control↓ IGF-1 gene expression across disease stagesNo difference in GH receptor staining intensity by the severity of NAFLD compared to that in the control group. The gene discussed is GHR; the disease is metabolic dysfunction-associated steatotic liver disease.